Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Comparison of the skin tumor-initiating activities of dihydrodiols, diol-epoxides, and methylated derivatives of various polycyclic aromatic hydrocarbons

Conference ·
OSTI ID:5287654
The abilities of dihydrodiols and diol-epoxides of dibenz(a,h)-anthracene (DB(a,h)A), dibenz(a,c)anthracene (DB(a,c)A), chrysene, 7-methylbenz(a)anthracene (7-MB(a)A), benzo(e)pyrene (B(e)P), and various methylated derivatives of benzo(a)pyrene (B(a)P), benz(a)anthracene (B(a)A), and 3-methylcholanthrene (3-MC) to initiate skin tumors in mice were determined. The trans-3,4-dihydrodiol of 7-MB(a)A, trans 9,10-dihydrodiol of B(e)P, and trans 1,2-dihydrodiol of chrysene were more active than their corresponding parent hydrocarbon when applied topically. The trans 3,4-dihydrodiol of DB(a,h)A had one-half of the tumor-initiating ability of DB(a,h)A. The trans 3,4-dihydrodiol of chrysene and trans 10-11-dihydrodiol of DB(a,c)A were inactive as skin tumor initiators. B(e)P-9,10-diol-11,12-epoxide, DB(a,h)A 3,4-diol-1,2-epoxide, DB(a,c)A 10,11-diol-12,13-epoxide, and 7-MB(a)A, 3,4-diol-1,2-epoxide were also inactive as tumor initiators. Chrysene 1,2-diol-3,4-epoxide had 25% of the activity of chrysene. Results show that the dihydrodiols of 7-MB(a)A, DB(a,h)A, and chrysene have moderate to high initiating activity, whereas the dihydrodiol B(e)P was inactive. The bay region diol-epoxide of chrysene was the only diol-epoxide tested that had significant activity compared to the parent hydrocarbon. Substitution of a methyl group in 7-MB(a)A, 12-MB(a)A, DMB(a)A, 3-MC, and B(a)P blocked the skin tumor-initiating activity. Likewise, substitution of a methyl group in the bay region of B(a)P and DMB(a)A decreased their tumor-initiating activity. (ERB)
Research Organization:
Oak Ridge National Lab., TN (USA); Ohio State Univ., Columbus (USA). Dept. of Chemistry; New Mexico Univ., Albuquerque (USA). Dept. of Chemistry; Chicago Univ., IL (USA). Ben May Lab. for Cancer Research
Sponsoring Organization:
USDOE Office of Health and Environmental Research
DOE Contract Number:
W-7405-ENG-26
OSTI ID:
5287654
Report Number(s):
CONF-791059--5
Country of Publication:
United States
Language:
English